A Survey of Korean Physicians’ Prescription Patterns for Allergic Rhinitis.
- Author:
Min Young SEO
1
;
Dong Kyu KIM
;
Hye Mi JEE
;
Young Min AHN
;
Yong Min KIM
;
Sang Duk HONG
Author Information
- Publication Type:Original Article
- Keywords: Allergic Rhinitis; Drug Prescriptions; Surveys and Questionnaires
- MeSH: Allergy and Immunology; Asthma; Classification; Desensitization, Immunologic; Diagnosis; Drug Prescriptions; Hospitals, General; Hypersensitivity; Internal Medicine; Korea; Leukotriene Antagonists; Otolaryngology; Pediatrics; Prescriptions*; Rhinitis, Allergic*; Seasons; Specialization; Surveys and Questionnaires
- From:Clinical and Experimental Otorhinolaryngology 2017;10(4):332-337
- CountryRepublic of Korea
- Language:English
- Abstract: OBJECTIVES: The aim of this study was to compare the prescription patterns according to characteristics of physicians using a survey distributed amongst physicians in Korea. METHODS: We surveyed the prescription patterns for allergic rhinitis (AR) of the members of the Korean Academy of Asthma, Allergy and Clinical Immunology (KAAACI) and the Korean Association of Otorhinolaryngologists (KAO). Questionnaire contained 4 categories with 28 queries. 448 physicians including 98 internal medicine (IM), 113 pediatrics (PED), and 237 otorhinolaryngology (ENT) were responded. RESULTS: Although the Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines are most frequently used in all specialties, seasonal or perennial AR is the most frequent classification system. For the definitive diagnosis of AR, ENT physicians reported using multiple allergen simultaneous test (MAST)/radio allergy sorbent test (RAST) more than others (IM, 10.9%; PED, 20.6%; ENT, 44.2%; P < 0.001). In treatment, most physicians reported that antihistamine medication is the initial treatment for AR. PED physicians prescribed fewer intranasal steroid to combinations with an antihistamine than other specialists (IM, 65.3%; PED, 42.5%; ENT, 63.3%), but preferred leukotriene antagonists (IM, 4.1%; PED, 23.0%; ENT, 3.9%; P=0.041). Overall, 53% (235/448) of the physicians performed allergen immunotherapy (AIT), and IM administers the most AIT (IM, 71.6%; PED, 42.0%; ENT, 39.5%; P=0.019). Furthermore, university and general hospital physicians prescribed more AIT than doctors at other hospital types (university hospital, 76.4%; general hospital, 64.3%; local hospital, 21.4%; private clinic, 20.2%; P < 0.001). CONCLUSION: The prescription patterns for AR were different according to the physicians’ characteristics and general rate of prescribing AIT is just about 53% in Korea. Thus, the development of complementary Korean-specific guidelines is needed and proper clinical instruction of AIT would be necessary.
